Anti-PRKACA (cAMP-dependent Protein Kinase Catalytic Subunit alpha, PKA C-alpha, PKACA)

Anti-PRKACA (cAMP-dependent Protein Kinase Catalytic Subunit alpha, PKA C-alpha, PKACA)
Artikelnummer Größe Datenblatt Manual SDB Lieferzeit Menge Preis
P9103-22M1.20 20 µl - -

3 - 19 Werktage*

509,00 €
P9103-22M1.100 100 µl - -

3 - 19 Werktage*

866,00 €
 
The second messenger cyclic AMP (cAMP) activates cAMP-dependent protein kinase (PKA or cAPK) in... mehr
Produktinformationen "Anti-PRKACA (cAMP-dependent Protein Kinase Catalytic Subunit alpha, PKA C-alpha, PKACA)"
The second messenger cyclic AMP (cAMP) activates cAMP-dependent protein kinase (PKA or cAPK) in mammalian cells and controls many cellular mechanisms such as gene transcription, ion transport, and protein phosphorylation. Inactive PKA is a heterotetramer composed of a regulatory subunit (R) dimer and a catalytic subunit (C) dimer. In this inactive state, the pseudosubstrate sequences on the R subunits block the active sites on the C subunits. Three C subunit isoforms (C-a, C-b, and C-y) and two families of regulatory subunits (RI and RII) with distinct cAMP binding properties have been identified. The two R families exist in two isoforms, a and b (RI-a, RI-b, RII-a, and RII-b). Upon binding of cAMP to the R subunits, the autoinhibitory contact is eased and active monomeric C subunits are released. PKA shares substrate specificity with Akt (PKB) and PKC, which are characterized by an arginine at position -3 relative to the phosphorylated serine or threonine residue. Substrates that present this consensus sequence and have been shown to be phosphorylated by PKA are Bad (Ser155), CREB (Ser133), and GSK-3 (GSK-3a Ser21 and GSK-3b Ser9). In addition, combined knock-down of PKA C-a and -b blocks cAMP-mediated phosphorylation of Raf (Ser43 and Ser259) (6). Autophosphorylation and phosphorylation by PDK-1 are two known mechanisms responsible for phosphorylation of the C subunit at Thr197. Applications: Suitable for use in Western Blot and Immunoprecipitation. Other applications not tested. Recommended Dilution: Western Blot: 1:1000, incubate membrane with diluted antibody in 5% BSA, 1X TBS, 0.1% Tween-20 at 4°C with gentle shaking, overnight., Immunoprecipitation: 1:50, Optimal dilutions to be determined by the researcher. Storage and Stability: May be stored at 4°C for short-term only. Aliquot to avoid repeated freezing and thawing. Store at -20°C. Aliquots are stable for 12 months after receipt. For maximum recovery of product, centrifuge the original vial after thawing and prior to removing the cap.
Schlagworte: EC=2.7.11.11, Anti-cAMP-dependent protein kinase catalytic subunit alpha
Hersteller: United States Biological
Hersteller-Nr: P9103-22M1

Eigenschaften

Anwendung: IP, WB
Antikörper-Typ: Monoclonal
Klon: D38C6
Konjugat: No
Wirt: Rabbit
Spezies-Reaktivität: hamster, human, monkey, mouse, rat
Immunogen: Synthetic peptide corresponding to residues surrounding Ser326 of human PKA C-a.
Format: Supernatant

Handhabung & Sicherheit

Lagerung: -20°C
Versand: +4°C (International: -20°C)
Achtung
Nur für Forschungszwecke und Laboruntersuchungen: Nicht für die Anwendung im oder am Menschen!
Hier kriegen Sie ein Zertifikat
oder , um Analysenzertifikate anzufordern.
Bewertungen lesen, schreiben und diskutieren... mehr
Kundenbewertungen für "Anti-PRKACA (cAMP-dependent Protein Kinase Catalytic Subunit alpha, PKA C-alpha, PKACA)"
Bewertung schreiben
oder , um eine Produktbewertung abzugeben.
Zuletzt angesehen